OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for October, 2016

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2016-10-31 12:15 2016’s drug pricing headwinds threaten a hurricane of new regulations and more... 2016-10-30 12:15 Can Keytruda Return Merck &amp; Co. to Growth? and more... 2016-10-30 00:15 Medtech IPOs of 2016 and more... 2016-10-29 00:15 Astellas furthers oncology focus with Ganymed buy and more... 2016-10-28 12:15 FDA approval could be delayed for Sanofi Genzyme’s next blockbuster and more... 2016-10-28 00:15 Bristol-Myers reshapes operations in wake of Opdivo miss and more... 2016-10-27 12:15 Bristol hikes 2016 profit forecast as top drugs deliver, shares jump and more... 2016-10-27 00:15 NCPA: FDA to blame for EpiPen price hikes and more... 2016-10-26 12:15 GlaxoSmithKline Beats Estimates in Strong Third Quarter and more... 2016-10-26 00:15 EpiPen prescriptions continue to climb, but market share dropped and more... 2016-10-25 12:15 Merck quarterly revenue beats, raises full-year forecast and more... 2016-10-25 00:15 FDA approves Merck's lung cancer drug as first-line treatment and more... 2016-10-24 12:15 GSK files potential $1 bln shingles vaccine for U.S. approval and more... 2016-10-24 00:15 Week In Review: Over $850 Million In China Healthcare And Pharma Deals and more... 2016-10-23 00:15 Are The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments and more... 2016-10-22 00:15 GSK exits U.S. market with its HPV vaccine Cervarix and more... 2016-10-21 12:15 Novartis May Be Too Generic and more... 2016-10-21 00:15 FDA official warns other drug makers not to copy Sarepta and more... 2016-10-20 12:15 Card-carrying pharma reps? Chicago eyes licensing for painkiller promoters and more... 2016-10-20 00:15 Pfizer anchors inflammation hopes in Xeljanz and more... 2016-10-19 12:15 Earnings guide: A preview of 9 big pharmas in Q3 and more... 2016-10-19 00:15 Roche's lung cancer drug wins U.S. approval and more... 2016-10-18 12:15 AstraZeneca backs ADC in $105M to support 6 clinical oncology candidates and more... 2016-10-18 00:15 Depomed agrees temporary truce with Starboard in proxy fight and more... 2016-10-17 12:15 FDA places Regeneron and Teva's pain-drug study on hold and more... 2016-10-17 00:15 Powerful Dems orchestrated campaign at FDA to provide Biogen drug to a dying, high-profile fundraiser and more... 2016-10-16 00:15 The FDA Missed Egalet's PDUFA Date, But Investors Should Not Be Worried and more... 2016-10-14 12:15 Mylan's next problem? A shareholder suit demanding damages and more... 2016-10-14 00:15 FDA’s controversial OK for eteplirsen spurs second thoughts for a rejected rival at BioMarin and more... 2016-10-13 12:15 Quadrivalent Influenza Vaccine Gains FDA Approval and more... 2016-10-13 00:15 ​R&amp;D spending takes a back seat to other costs at Boston’s biggest biotechs and more... 2016-10-12 12:15 Is Biopharma Productivity In A Sharp Decline? and more... 2016-10-12 00:15 3 Biotechs Most Likely to Be Acquired and more... 2016-10-11 12:15 One Mom Is So Mad About Vertex's Pricey CF Drugs She's Taking On The CEO and more... 2016-10-11 00:15 Eli Lilly Is Waiting for a Catalyst and more... 2016-10-10 12:15 No silver lining in failed Bristol cancer drug trial and more... 2016-10-09 00:15 Pre-surgery use of Bristol's Opdivo 'safe and feasible' in lung cancer, study shows and more... 2016-10-08 00:15 EpiPen Maker Mylan Agrees To $465 Million Settlement With DOJ and more... 2016-10-07 12:15 Pfizer to Sell Its Aging Headquarters and more... 2016-10-06 12:15 Mylan overcharged Medicaid for EpiPen for years, despite warnings and more... 2016-10-06 00:15 Cempra Releases Promising Phase II Clinical Trial Results For Anti-NASH Drug and more... 2016-10-05 12:15 Pain at Insys Therapeutics and more... 2016-10-05 00:15 FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hepatitis B Reactivation Risk and more... 2016-10-04 12:15 Mylan takes on punching-bag role again as Clinton aims to shame 'bad actors' and more... 2016-10-04 00:15 Depomed protects Nucynta investment and more... 2016-10-03 12:15 When You Have To Sign a Non-Compete Agreement - Discussion With An Employment Attorney (part 2 of 2) and more... 2016-10-02 12:15 Why Pfizer's Scrapped Merger May Ultimately Benefit the Company and Investors and more... 2016-10-01 00:15 Why Novo Nordisk Expects Double-Digit Growth in Diabetes Care in 2016 and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe